|
Gregory I. Berk, M.D., was appointed as our Vice President, Chief Medical Officer in October 2005, and in December 2005 was named Senior Vice President, Chief Medical Officer. From January 2003 to October 2005, Dr. Berk was Medical Director for Network of Medical Communications and Research, a consulting and medical education company, which focuses on oncology clinical research. From July 1990 to December 2002, Dr. Berk practiced oncology in New York as a partner in Richard T. Silver, M.D. and Gregory I. Berk, M.D., P.C. and was Attending Physician, Department of Medicine at New York Presbyterian Hospital (Cornell Campus) from June 1989 to December 2002. From July 1995 to December 2002, Dr. Berk was Assistant Professor of Medicine, Weill Medical College, Cornell University, New York, where he also served an investigator in numerous clinical trials for oncology product candidates, including the Gleevec pivotal trials, Avastin (bevacizumab) colorectal and breast trials, and several CALGB studies. Dr. Berk received a B.S. from Tulane University and an M.D. from Case Western Reserve University School of Medicine. | 